tumor expansion trial
Scope
Date
~
-
Bio & Pharma
NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...
Oct 26, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Leadership & Management
Mirae Asset promotes Indian unit head to vice chairman
Mirae Asset Financial Group, South Korea’s leading financial conglomerate, on Monday promoted Swarup Mohanty, the head of its Indian asset man...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
Korean startups
Ably's amood to support K-fashion's expansion into Japan
South Korean fashion commerce platform Ably Corp. announced on Wednesday its Japanese shopping platform amood starts a one-stop service for domestic...
Oct 18, 2023 (Gmt+09:00)
-
Automobiles
KCC opens US refinish color center
South Korean chemical and auto parts maker KCC Corp. opened its first overseas refinish color center in the US. According to the company's anno...
Oct 13, 2023 (Gmt+09:00)
-
Korean food
Lotte Wellfood ups Choco Pie India sales target to $60 mn with new factory
Lotte Wellfood Co., formerly Lotte Confectionery Co., has revised up this year’s Choco Pie sales forecast in India to 80 billion won ($60 mill...
Oct 10, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax's US subsidiary listed on Nasdaq
South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Globa...
Oct 05, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to conduct Phase 3 trials in Thailand for gout treatment
South Korea's JW Pharmaceutical Corp. on Thursday said it received approval from Thailand's Food and Drug Administration to conduct Phase 3 clinical...
Sep 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
Sep 20, 2023 (Gmt+09:00)
-
Fintech
Kakao Pay’s tie-up with Alipay spurs growth in China
BEIJING – Kakao Pay Corp., the mobile payment service unit of South Korean tech giant Kakao Corp., is rapidly growing in China’s fintech...
Sep 20, 2023 (Gmt+09:00)
-
Construction
Hyundai E&C seeks expansion to Poland, Ukraine
South Korea's Hyundai Engineering & Construction (E&C) will open a branch in Warsaw, Poland, to join a project to build small modular reacto...
Sep 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong to develop eye drops for diabetic retinopathy
South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...
Sep 15, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
HMM embarks on biofuel ship pilot testing on global route
South Korea has begun a pilot operation of a biofuel-powered container ship on a global route, the government said on Friday. HMM Co.'s container sh...
Sep 15, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell Bio's treatment shows promise for advanced liver cancer
South Korea's VaxCell Biotherapeutics Co. on Tuesday said its treatment for advanced liver cancer under development stopped or greatly reduced the g...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Wellmarker Bio signs worth of $528 mn tech transfer deal
Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...
Sep 12, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio applies for Phase 3 clinical trials in China for oral dementia drug
South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...
Sep 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Yungjin Pharm's new drug candidate gets Fast Track from FDA
South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...
Sep 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Aug 22, 2023 (Gmt+09:00)
-
Korean Investors
Korea taps Greyhound Capital, Headline Asia as venture fund managers
South Korean Ministry of SMEs and Startups announced the results of selecting global fund management companies for the year 2023 on Monday. The chos...
Aug 21, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma gets OK for phase 3 clinical trials of URC102 in Taiwan
South Korea's JW Pharmaceutical has won approval from Taiwan's Food and Drug Administration (TFDA) to conduct phase 3 clinical trials for its gout t...
Aug 18, 2023 (Gmt+09:00)
-
Business & Politics
Camp David Summit to Unite U.S., South Korea, Japan
WASHINGTON—A new trilateral alliance linking the U.S., South Korea and Japan will enhance cooperation among the nations in key areas, includin...
Aug 17, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Taihan Cable posts highest first-half operating profit in 20 years
South Korea's Taihan Cable & Solution Co. announced on Friday that its consolidated operating profit for the first half of this year reached 41....
Aug 11, 2023 (Gmt+09:00)
-
Economy
S.Korean think-tank lifts inflation forecast on oil prices
A South Korean government think-tank has raised its inflation prediction for this year due to the recent rise in oil prices and expectations that As...
Aug 10, 2023 (Gmt+09:00)
-
Bio & Pharma
ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug
New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...
Aug 10, 2023 (Gmt+09:00)
-
Construction & Planning
Hyundai Elevator sets sights on global ‘Top 5’ ranking by 2030
Shanghai Hyundai Elevator, a subsidiary of South Korea’s Hyundai Elevator Co., unveiled on Thursday an ambitious plan to bolster its market sh...
Aug 10, 2023 (Gmt+09:00)
-
Airlines
Budget carriers turn around with highest-ever profits in Q2
South Korea’s low-cost carriers (LCCs) posted their highest-ever quarterly profits on the back of a surge in international travel as the indus...
Aug 08, 2023 (Gmt+09:00)
-
Electric vehicles
LG Uplus to grow EV charging JV to be among Korea’s top 3
LG Uplus Corp., South Korea’s third-largest mobile carrier, aims to develop its electric vehicle charging joint venture with Kakao Mobility Co...
Aug 08, 2023 (Gmt+09:00)
-
Robotics
LG Uplus announces expansion of robot business from serving to logistics
South Korea’s third-largest mobile carrier, LG Uplus Corp., said on Monday that it will expand its robot business from the existing serving se...
Aug 07, 2023 (Gmt+09:00)